NGM Biopharmaceuticals, Inc.
Clinical trials sponsored by NGM Biopharmaceuticals, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug aims to stop cancer wasting in colorectal patients Results expected Apr 2027 (estimated)